Results 1 to 10 of about 3,390,641 (355)

Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections [PDF]

open access: goldJAMA Network Open, 2022
Key Points Question What are the temporal and regional trends in the proportion of macrolide-resistant Mycoplasma pneumoniae (MRMP) infections? Findings In this systematic review and meta-analysis of 150 articles including 27 408 samples, the proportion ...
Kyunghoon Kim   +5 more
openalex   +2 more sources

Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development

open access: yesPathogens, 2021
Mycoplasma pneumoniae is a major causative agent of community-acquired pneumonia which can lead to both acute upper and lower respiratory tract inflammation, and extrapulmonary syndromes. Refractory pneumonia caused by M.
Zhulin Jiang   +4 more
semanticscholar   +1 more source

P-656. Epidemiology of Mycoplasma pneumoniae Infections after COVID-19 Pandemic [PDF]

open access: goldOpen Forum Infect Dis
Lakshmi Marimuthu   +3 more
europepmc   +2 more sources

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia

open access: yesEmerging Infectious Diseases, 2020
A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been reported in Asia. We performed a systematic review and meta-analysis to investigate the effect of macrolide resistance on the manifestations and clinical judgment during ...
Yu-Chin Chen   +2 more
semanticscholar   +1 more source

Mycoplasma bovis Infections—Occurrence, Diagnosis and Control

open access: yesPathogens, 2020
Mycoplasma bovis is a cause of bronchopneumonia, mastitis and arthritis but may also affect other main organs in cattle such us the eye, ear or brain. Despite its non-zoonotic character, M. bovis infections are responsible for substantial economic health
K. Dudek   +3 more
semanticscholar   +1 more source

Sexually Transmitted Infections Treatment Guidelines, 2021

open access: yesMMWR Recommendations and Reports, 2021
Summary These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11–14,
K. Workowski   +8 more
semanticscholar   +1 more source

Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016

open access: yesEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020
Background Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia, with large epidemics previously described to occur every 4 to 7 years. Aim To better understand the diagnostic methods used to detect M. pneumoniae; to better understand
M. Beeton   +12 more
semanticscholar   +1 more source

Hemotropic mycoplasmas in little brown bats (Myotis lucifugus). [PDF]

open access: yes, 2014
BackgroundHemotropic mycoplasmas are epicellular erythrocytic bacteria that can cause infectious anemia in some mammalian species. Worldwide, hemotropic mycoplasmas are emerging or re-emerging zoonotic pathogens potentially causing serious and ...
Breitschwerdt, Edward B   +5 more
core   +2 more sources

Epidemiology of genital infections caused by Mycoplasma hominis, M. genitalium and Ureaplasma urealyticum in Iran; a systematic review and meta-analysis study (2000–2019)

open access: yesBMC Public Health, 2020
Although many species of mycoplasmas regard as normal flora, but some species causes serious genital disease. In Iran several epidemiological studies have documented the prevalence of Mycoplasma hominis, M.
Khadijeh Moridi   +5 more
semanticscholar   +1 more source

'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women.' [PDF]

open access: yes, 2016
BACKGROUND Differences in the determinants of Chlamydia trachomatis ('chlamydia') and Mycoplasma genitalium (MG) genital infection in women are not well understood.
Birden, Hudson   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy